Pablo is the founder and CEO of Antidote. Since 2009, under his leadership, the company (formerly known as TrialReach) has raised almost $20m in venture capital and grown to become a leading player within the digital health sector, empowering thousands of patients worldwide to discover and access potential new treatment options.

Pablo is a seasoned entrepreneur and manager of Internet companies, building high-scale businesses in online retail, travel, mobile, media, and health sectors since the late 90s, including firms such as NetJuice, DondeComprar.com, Kelkoo.com (acquired by Yahoo!), Kayak.com (acquired by Priceline), and ValueClick (acquired by Conversant).

Pablo has spoken about technology, healthcare, and innovation at Harvard Medical School, DIA, Disruptive Innovations, Health 2.0, Digital Health Forum, and many others. He was recently included in the “100 Club” by SVC2UK and the “Ones To Watch” list by The Sunday Times’ Tech Track 100. He’s also been featured in the Financial Times, Forbes, TechCrunch.